Vimta Labs Limited Stock

Equities

VIMTALABS

INE579C01029

Biotechnology & Medical Research

Market Closed - Bombay S.E. 06:00:48 2024-05-10 am EDT 5-day change 1st Jan Change
489.5 INR +1.64% Intraday chart for Vimta Labs Limited -6.55% +21.22%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2022 2.79B 33.38M Sales 2023 3.19B 38.21M Capitalization 6.95B 83.29M
Net income 2022 413M 4.95M Net income 2023 482M 5.77M EV / Sales 2022 2.53 x
Net Debt 2022 85.41M 1.02M Net cash position 2023 242M 2.89M EV / Sales 2023 2.1 x
P/E ratio 2022
17.2 x
P/E ratio 2023
14.7 x
Employees 1,368
Yield 2022
0.63%
Yield 2023
0.64%
Free-Float 30.69%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.64%
1 week-6.55%
Current month-8.77%
1 month+0.65%
3 months-3.31%
6 months+22.24%
Current year+21.22%
More quotes
1 week
480.00
Extreme 480
529.05
1 month
444.90
Extreme 444.9
600.00
Current year
400.15
Extreme 400.15
600.00
1 year
365.00
Extreme 365
621.40
3 years
215.60
Extreme 215.6
621.40
5 years
51.05
Extreme 51.05
621.40
10 years
51.05
Extreme 51.05
621.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 94-12-31
Founder 75 83-12-31
Director of Finance/CFO - 21-02-21
Members of the board TitleAgeSince
Founder 75 83-12-31
Chief Operating Officer 72 83-12-31
Chief Executive Officer 49 94-12-31
More insiders
Date Price Change Volume
24-05-10 489.5 +1.64% 1,817
24-05-09 481.6 -3.31% 1,886
24-05-08 498.1 +0.49% 3,106
24-05-07 495.6 -2.57% 6,588
24-05-06 508.7 -2.88% 4,207

Delayed Quote Bombay S.E., May 10, 2024 at 06:00 am EDT

More quotes
Vimta Labs Limited is engaged in the business of contract research and testing organization. The Company is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include Drug discovery, development, and drug life cycle management support services; Preclinical research and testing services for medical device companies; Contract research and testing for agrochemical and specialty chemical companies; and Food testing and analytical development services to support manufacturers, processors, farmers, and retailers; Clinical diagnostics services to patients, clinicians, and hospitals, and environmental regulatory services such as impact assessments and post project monitoring, to various industries, such as power and infrastructure.
More about the company
  1. Stock Market
  2. Equities
  3. VIMTALABS Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW